Surgical Science Offer
Announcement
Scheme Document
Rule 2.7 Announcement
Surgical Science – Nasdaq Announcement to 2.7 (18 Dec 24) (vF)
Surgical Science – Nasdaq Announcement to 2.7 (SWE) (18 Dec 24) (vF)
Surgical Science – Investor Presentation (vF)
Confidentiality Agreement(457032830.1)
Co-operation Agreement (Redacted)
Irrevocable Undertaking from Stuart Gall (Director)
Irrevocable Undertaking from Helen Jones (Director)
Irrevocable Undertaking from Ingeborg Dybdal Oie (Director)
Irrevocable Undertaking from Riccardo Pigliucci (Director)
Irrevocable Undertaking from Nicholas Avis (Director)
Irrevocable Undertaking from Parkwalk Advisors Ltd (Shareholder)
Irrevocable Undertaking from IP2IPO Limited (Shareholder)
Irrevocable Undertaking from IP Venture Fund II (GP) LLP (Shareholder)
Irrevocable Undertaking from IP2IPO Portfolio (GP) Limited (Shareholder)
Irrevocable Undertaking from Polar Capital Global Healthcare Trust plc (Shareholder)
Letter of Intent from Amati Global Investors Limited (Shareholder)
Consent Letter – Pareto Securities AB (Redacted)
Consent Letter – Strand Hanson (Redacted)
Consent Letter – Cavendish Capital Markets Limited (Redacted)
Danske Bank Facility (in Swedish, with English translation)(Redacted)
Rule 2.11 Letter to employees – Project Saturn – (dated)_Redacted
Rule 2.11 Letter to shareholders – Project Saturn (dated)_Redacted
Cavendish Consent Letter – Scheme Document
Form of Proxy – Court Meeting
Form of Proxy – General Meeting
Intelligent Ultrasound – Articles of Association (Current)
Intelligent Ultrasound – Articles of Association (Proposed Scheme)
Intelligent Ultrasound – Audited Accounts for the Financial Year ended 31 December 2022
Intelligent Ultrasound – Audited Accounts for the Financial Year ended 31 December 2023
Intelligent Ultrasound – Unaudited Interim Results for the Six Months ended 30 June 2024
Nasdaq Announcement – Publication of Scheme Document (ENG)
Nasdaq Announcement – Publication of Scheme Document (SWE)
Notice of Availability of Scheme Document – Letter
Pareto – Consent Letter – Scheme Document
Surgical Science –Second Quarter 2024 Interim Results – 22 August 2024
Strand Hanson – Consent Letter – Scheme Document
Surgical Science – Articles of Association (English)
Surgical Science – Articles of Association (Swedish)
Surgical Science – Audited Accounts for the Financial Year ended 31 December 2022
Surgical Science – Audited Accounts for the Financial Year ended 31 December 2023
Surgical Science – First Quarter 2024 Interim Results – 15 May 2024
Surgical Science – Third Quarter 2024 Interim Results – 14 November 2024
Project Saturn – Rule 15 Letter – Option Holders – 15 January 2025.DOCX_Redacted
Project Saturn – Underwater Options – Letter -15 January 2025.DOCX_Redacted
Notice of Availability of Scheme Document – Email
Form 8 – Opening Position Disclosure (Replacement) (20.1.25)
Form 8 – Opening Position Disclosure (20.12.24)